Los Angeles Talc Mesothelioma Verdict — Judge Tosses $950M in Punitive Damages While J&J Product Liability Finding Stands
If you are reading this because someone you love developed mesothelioma after years of using baby powder, or because you yourself received a diagnosis and you are sitting at a kitchen table at 2 a.m. trying to understand what a $966 million verdict with $950 million reversed actually means for your family — keep reading. We are going to explain exactly what happened in that Los Angeles courtroom, what the judge’s ruling does and does not undo, and what it means for anyone who suspects talc caused their cancer.
Here is the first thing you need to hear, and it matters more than any headline: the jury’s finding that Johnson & Johnson’s talc product caused a woman’s mesothelioma was not overturned. The judge struck down the punishment portion of the award — the $950 million in punitive damages — but the liability finding, the causation finding, and approximately $16 million in compensatory damages remain on the books. The fight is not over. It has moved to a different phase.
A Los Angeles Superior Court jury returned a $966 million verdict against Johnson & Johnson on October 6 in a talc litigation matter brought by the children of a woman who died of mesothelioma in 2021 after allegedly using J&J baby powder contaminated with asbestos. The judge subsequently threw out $950 million of that verdict — the punitive damages portion — concluding the evidence failed to show J&J acted with malice or concealed knowledge that its talc contained asbestos. The ruling leaves approximately $16 million in compensatory damages intact while eliminating 98% of the original award’s dollar value. Plaintiffs’ counsel has announced plans to appeal. The case produced one of the largest talc verdicts to date and the second-largest in 2025.
That last paragraph is what the news reported. What follows is what a trial team that has spent decades in courtrooms wants you to understand about it — because the legal machinery behind that headline is where your rights live.
What the Verdict Reversal Actually Means — and What It Does Not Touch
The most important distinction in this ruling is the one the headline buries: the compensatory verdict and the punitive verdict are legally separate findings, built on different evidentiary standards, and the judge attacked only one.
Compensatory damages — the roughly $16 million that survived — represent the jury’s assessment of what the injury is actually worth: the medical treatment, the lost income, the pain and suffering, the fear of dying, the loss of the relationship between a mother and her children. The jury found that J&J’s product caused the mesothelioma. That finding is intact. The judge did not reverse the liability determination. She did not say the product was safe. She did not say the cancer came from somewhere else. She said the evidence was not strong enough, under California’s punitive damages statute, to prove the company acted with malice or concealed what it knew.
Punitive damages — the $950 million that was vacated — are different. They are not compensation for harm suffered. They are punishment. They exist to deter and to send a message. And California sets a meaningfully higher bar for them than for compensation.
California Civil Code § 3294 governs punitive damages and requires clear and convincing evidence of “malice, oppression, or fraud” — defined by the statute as “despicable conduct which is carried on by the defendant with a willful and conscious disregard of the rights or safety of others.”
That phrase — clear and convincing evidence of despicable conduct carried on with willful and conscious disregard — is the wall the plaintiffs did not clear in this judge’s assessment. It is a high bar. It is supposed to be a high bar. But here is the thing about high bars in litigation: they are appellate arguments waiting to happen, and the plaintiffs’ team has already said they will make that argument.
The appeal will likely target whether the trial judge applied the correct legal standard. California’s § 3294 malice standard requires clear and convincing evidence — but the question on appeal is whether the judge evaluated the evidence under the correct sufficiency standard (which is deferential to the jury’s factual findings) or whether she improperly reweighed the jury’s factual determinations about what J&J knew and when. Those are two very different things. A trial judge who replaces the jury’s factual assessment with her own is committing legal error — and that is exactly the argument the appeal will press.
The Asbestos-in-Talc Regulatory Gap — Why This Litigation Exists at All
To understand why this case even exists — why anyone is suing over baby powder — you need to understand a regulatory gap that most consumers never learn about until it is too late.
The FDA regulates cosmetic talc products under the Federal Food, Drug, and Cosmetic Act. But the FDA does not require pre-market approval of cosmetic talc products. The FDA does not require testing for asbestos contamination in cosmetics. There is no federal mandate that a company selling baby powder must prove its product is asbestos-free before it reaches a store shelf. The regulatory framework treats cosmetic talc as a cosmetic, not as a potential carcinogen exposure pathway — even though the geological reality is that talc and asbestos are both silicate minerals that co-occur in the earth, and mining one can harvest the other.
The EPA regulates asbestos under the Toxic Substances Control Act and has historically classified asbestos as a hazardous air pollutant. The talc-asbestos co-occurrence is recognized in geological and industrial hygiene literature. OSHA regulates workplace asbestos exposure under 29 CFR 1910.1001, establishing permissible exposure limits that inform the scientific baseline for what constitutes hazardous asbestos exposure. FDA surveys of cosmetic talc products have detected asbestos in certain samples using transmission electron microscopy — the analytical method capable of distinguishing asbestos fibers from ordinary talc particles at the microscopic level.
So the regulatory picture is this: the government knows asbestos is dangerous. The government knows asbestos can contaminate talc. The government’s own surveys have found asbestos in cosmetic talc products. But no federal agency requires a cosmetics company to test its talc for asbestos before selling it to consumers. That regulatory gap is the space product liability litigation was built to fill — because when the government does not force a company to test, the only force that can make it accountable is a jury.
The plaintiffs’ argument in talc litigation is that Johnson & Johnson voluntarily assumed a duty to ensure its product was safe — a duty the company took on the moment it put “Johnson & Johnson” on the bottle and “baby powder” on the label — and then breached that duty by not adequately testing for, or eliminating, the asbestos contamination that its own internal testing allegedly detected over decades.
Johnson & Johnson’s Corporate Structure — The Talc Liability Shell Game
If you are considering a talc claim, you need to understand who you are actually suing — because Johnson & Johnson has engineered one of the most complex corporate liability structures in American mass tort history.
The parent company is Johnson & Johnson. The historical talc seller was Johnson & Johnson Consumer Inc. (JJCI). But the talc liability has been shuffled through a chain of entities designed to wall it off from the company’s primary assets:
LTL Management LLC was the entity created through a “Texas two-step” divisional merger — a corporate maneuver that splits a company into two entities, one receiving the valuable assets and the other receiving the talc liability, which then files for bankruptcy. LTL filed Chapter 11 twice. Both attempts were dismissed by the courts.
Red River Talc LLC was the renamed successor liability vehicle used for a third bankruptcy attempt. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed Red River Talc’s prepackaged Chapter 11 — J&J’s third failed bankruptcy bid. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases.
Kenvue Inc. is the consumer-health spinoff from J&J (the entity that now owns Band-Aid, Tylenol, Listerine and other consumer brands). J&J has indemnity arrangements with Kenvue, but Kenvue is a separate publicly traded company.
The three failed bankruptcy attempts tell you something important about J&J’s litigation strategy: the company has been working to resolve tens of thousands of talc claims outside the individual tort system — through a global settlement funded inside a bankruptcy structure — rather than fighting them one by one in courthouses across the country. Each time a court rejected that approach, the cases went back to the tort system. And in the tort system, Los Angeles juries have shown they are willing to render significant verdicts.
As of June 2026, more than 68,000 talc cases were consolidated in the federal multidistrict litigation — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — before Judge Michael A. Shipp in the District of New Jersey. That number tells you the scale of the litigation. When 68,000 people have filed suit making the same claim against the same company over the same product, the question is not whether there is a problem. The question is how the legal system chooses to address it.
The largest talc verdict to survive appellate review is the Ingham v. Johnson & Johnson case from Missouri. A jury returned a $4.69 billion verdict in July 2018 for 22 plaintiffs. The Missouri Court of Appeals reduced it to approximately $2.12 billion in June 2020. The Missouri Supreme Court denied review. The U.S. Supreme Court denied certiorari on June 1, 2021 — meaning the reduced $2.1 billion award stands as final. That is not a press release number. That is a number the highest court in the country let stand. Past results depend on the facts of each case and do not guarantee future outcomes — but the Ingham result tells you these cases can produce real, affirmed, collectible outcomes.
Mesothelioma — The Signature Asbestos Disease
Mesothelioma is a cancer of the pleura — the thin lining that surrounds the lungs — and sometimes of the peritoneum, the lining of the abdomen. It is essentially specific to asbestos exposure. That is not a plaintiff’s lawyer’s argument; it is settled medical science. The World Health Organization’s International Agency for Research on Cancer classifies all forms of asbestos as Group 1 carcinogens — substances definitively known to cause cancer in humans. Mesothelioma is so rare in the general population, and so strongly associated with asbestos exposure, that a diagnosis itself is near-conclusive evidence that asbestos exposure occurred somewhere in the person’s history.
The mechanism is physical and relentless. Inhaled asbestos fibers — durable, microscopic, sharp — lodge in the pleural lining. The body cannot break them down or clear them. Over decades, the chronic irritation and genotoxic damage they cause drives malignant transformation of the mesothelial cells. The fiber’s near-indestructibility is why a single exposure window, even decades earlier, can seed the disease.
The latency is the cruelest part. Mesothelioma typically appears 20 to 50 years after first exposure, most commonly in a 30 to 40 year window. A woman who used baby powder daily in her twenties and thirties may not develop symptoms until her sixties or seventies. By then, the exposure is a distant memory. The baby powder bottle is long gone. The connection between a daily hygiene routine from forty years ago and a cancer diagnosis today is not something most people make on their own — which is exactly why the discovery rule matters so much in these cases.
Median survival from diagnosis is 12 to 21 months. The disease trajectory is devastating: progressive shortness of breath, chest pain, fluid accumulation around the lungs, weight loss, and eventual respiratory failure. Treatment options include surgery (pleurectomy/decortication or extrapleural pneumonectomy), chemotherapy (typically pemetrexed and cisplatin), immunotherapy, and palliative care. But mesothelioma is almost always fatal, and the timeline from diagnosis to death is compressed into a window that leaves families reeling.
In the Los Angeles case, the decedent was diagnosed and died in 2021 — a survival period of months, not years, compressed into the most devastating window mesothelioma can produce. Her children’s wrongful death claims include the loss of their mother’s financial support, companionship, guidance, and society. Survival damages under California law capture the decedent’s pre-death pain, suffering, and medical expenses — the terror and agony of knowing you are dying from a product you trusted since childhood.
California Law: Why the Compensatory Verdict Is Strong and the Punitive Reversal Is Appealable
California applies strict products liability under the Restatement approach codified through California Supreme Court precedent. This means a manufacturer is liable for a defective product without the plaintiff needing to prove negligence — the defect itself is the breach. For a talc product containing asbestos, the theories are:
Design defect — a product containing a known carcinogen without adequate warning is defectively designed. California applies both the consumer expectation test (would an ordinary consumer expect baby powder to contain asbestos?) and the risk-benefit test (did the risks of the design outweigh its benefits, and was a safer alternative available?).
Failure to warn — J&J allegedly failed to warn consumers that its talc products could contain asbestos fibers, depriving users of the opportunity to make informed decisions about exposure to a known carcinogen linked to mesothelioma.
Negligence — the company allegedly breached its duty of reasonable care in sourcing, testing, manufacturing, and marketing talc products, failing to implement adequate asbestos detection and elimination protocols despite industry and scientific awareness of talc-asbestos co-occurrence.
Fraudulent concealment — plaintiffs alleged J&J knew or should have known its talc contained asbestos and concealed this knowledge. The trial judge found this theory insufficiently supported by evidence for punitive purposes — but it remains part of the compensatory liability framework and is a central appellate target.
Here is the critical legal point: California has no statutory cap on compensatory damages in product liability cases. There is no ceiling on what a jury can award for medical costs, lost earnings, pain and suffering, and loss of consortium in a products liability case. That is a significant advantage for plaintiffs in California compared to states that cap non-economic damages. The $16 million compensatory award in this case — while a fraction of the original $966 million — is not capped, and it reflects the jury’s honest assessment of what this woman’s suffering and her family’s loss are worth.
The punitive damages, by contrast, are constrained by both the § 3294 evidentiary standard (clear and convincing evidence of malice) and by federal due process principles that limit the ratio of punitive to compensatory damages. The U.S. Supreme Court has articulated these constraints in a line of cases that make extremely large punitive awards constitutionally vulnerable — which is part of why J&J’s litigation leadership called the original verdict “patently unconstitutional” and part of why the trial judge may have been attuned to the constitutional vulnerability of a $950 million punitive award paired with a $16 million compensatory award (a ratio of nearly 60:1).
But the appellate argument is not about the ratio. It is about whether the judge applied the correct standard when she found the evidence insufficient for malice. And that argument has teeth — because discovery in related talc cases against J&J, across multiple jurisdictions, has produced internal corporate documents that plaintiffs argue show decades of testing detecting asbestos in J&J talc. If those exhibits were in the trial record, the appellate brief will marshal every one of them, arguing the trial court erred in characterizing this evidence as insufficient to meet the § 3294 standard.
The Appellate Roadmap — How Punitive Damages Can Come Back
The appeal will focus on several specific legal arguments. Here is what the roadmap looks like:
The standard-of-review argument. The primary appellate argument targets the legal standard the trial judge applied. California’s § 3294 malice standard requires clear and convincing evidence — but the appellate court reviews the trial court’s evidentiary ruling under a specific standard of review. If the appellate court finds the judge conflated the sufficiency-of-evidence standard (which asks whether any reasonable jury could find malice by clear and convincing evidence) with her own reweighing of the jury’s factual findings on J&J’s knowledge and concealment, that is reversible error. The question is not whether the judge would have found malice — it is whether the evidence, viewed in the light most favorable to the verdict, was legally sufficient to support the jury’s finding.
The internal-documents argument. Discovery in related talc cases has produced internal J&J documents — testing results, corporate communications about asbestos detection, and marketing strategy documents — that plaintiffs argue demonstrate actual knowledge and concealment. The appellate brief will need to cite every exhibit supporting actual knowledge and concealment, arguing the trial court erred in characterizing this evidence as insufficient. The strength of this argument depends entirely on what was in the trial record — the appellate court cannot consider new evidence.
The jury-instruction argument. The specific instructions given on malice, concealment, and punitive damages — versus what plaintiffs requested — will be central to the appellate argument. If the jury was improperly constrained in its consideration of the malice question, or if the instructions did not accurately state the § 3294 standard, that is instructional error that could support reversal.
The compensatory defense. While the plaintiffs appeal the punitive reversal, J&J may cross-appeal or file remittitur motions challenging the $16 million compensatory award as excessive. The defense will argue the compensatory amount is not supported by the evidence of injury severity. The plaintiffs’ counter is the mesothelioma injury itself — a terminal cancer with median survival of 12 to 21 months, producing extraordinary pain and suffering — which anchors the excessiveness challenge. In a no-cap state like California, the compensatory award has strong protection.
The settlement leverage. Mediation or global settlement discussions may run concurrently with the appeal. J&J’s multi-jurisdictional talc exposure — 68,000+ cases in the MDL alone, plus state court actions across the country — creates pressure points that a single large verdict, even reduced, can exploit. The company has already attempted three bankruptcy settlements. The fact that those attempts failed means the cases are in the tort system, and every verdict — even one with the punitives reversed — adds to the aggregate pressure.
The Evidence Clock — What Must Be Preserved Now
If you are reading this because you or a loved one has been diagnosed with mesothelioma and you believe talc products may be the cause, the evidence clock is already running. Here is what exists, who holds it, and how fast it can disappear.
Your medical records. The diagnostic trail — imaging, biopsy pathology, immunohistochemistry results, treatment records — is the foundation of your case. These records establish the diagnosis, the cell type, the stage, and the treatment timeline. Hospital and clinic records are retained on varying schedules but are generally durable. Request complete copies immediately.
Your product usage history. Talc litigation requires product identification — proof that you used the specific product. For baby powder, this means establishing a pattern of regular use: what brand, how frequently, over what period. Photographs of product bottles, receipts, family testimony, and even the physical product containers themselves (if still in the home) are all evidence. Memories fade. Family members who can corroborate your usage history should be identified and their recollections documented now.
Your exposure timeline. Mesothelioma’s 20 to 50 year latency means the relevant exposure period may have been decades ago. Reconstructing where you lived, what products you used, and what other asbestos exposures you may have had (occupational, environmental, secondary) is critical — because the defense will argue your mesothelioma came from somewhere other than talc. A detailed exposure history, built with the help of family members who can fill in gaps, is the spine of the causation case.
Internal J&J documents. The discovery produced in the MDL and in state court talc litigation has generated a vast library of internal corporate documents — testing results, communications, marketing strategies — that plaintiffs’ counsel can access. These documents are the core of the punitive damages case. They are not your personal evidence to preserve; they exist in the litigation record. But your counsel must ensure the specific exhibits relevant to your case are designated and cited properly.
The statute of limitations. California’s statute of limitations for personal injury and wrongful death claims is two years under Code of Civil Procedure § 335.1. But for mesothelioma and other latent diseases, California applies the discovery rule — the clock does not start on the date of exposure. It starts when the plaintiff knew or reasonably should have known of the injury and its cause. For a mesothelioma patient, that is typically the date of diagnosis — or the date a doctor first told the patient the disease was connected to asbestos exposure. This means a person diagnosed last year likely still has time to file. But the discovery rule has limits, and some states impose an outer statute of repose that can cut off a claim even before discovery. This is why the single most important call is to a lawyer who can evaluate the specific deadline for your situation.
What a Talc Mesothelioma Case Is Worth — Honest Valuation
No honest lawyer can tell you what your case is worth without reviewing the medical records, the exposure history, and the specific product identification evidence. But the landscape of talc verdicts and settlements provides a framework.
Compensatory damages in a mesothelioma case reflect the severity of the injury — and mesothelioma is among the most severe injuries the civil justice system recognizes. Medical treatment costs (chemotherapy, radiation, surgery, palliative care), lost wages and earning capacity, and non-economic damages for the severe pain, suffering, and fear of death are all recoverable. In California, with no cap on compensatory damages, a mesothelioma verdict can reach well into the millions based on the injury alone. The $16 million compensatory award in the Los Angeles case is within the range that mesothelioma verdicts produce in California.
Punitive damages are the variable that can transform a case’s value. When the evidence supports a finding of corporate malice or concealment — and the evidence in the J&J talc litigation includes internal documents that plaintiffs argue demonstrate decades of asbestos detection in company testing — punitive damages can multiply the case value many times over. The original $950 million punitive award in this case, if restored on appeal, would make the total recovery nearly $1 billion. If the appellate court orders a new trial on punitives, the second jury could produce a substantial award — or a smaller one.
Settlement value is driven by the aggregate pressure of the litigation. J&J has more than 68,000 cases pending in the MDL. The company has attempted three bankruptcy settlements — all failed. Each verdict, even reduced, adds to the pressure to resolve the litigation globally. Settlement discussions may produce offers that exceed the bare compensatory figure even where the punitive appeal faces headwinds.
The honest range for a talc mesothelioma case in California, depending on the strength of the product identification evidence, the age and earning history of the plaintiff, the persuasiveness of the concealment evidence, and the procedural posture: from the compensatory baseline (multiple millions for a mesothelioma death in a no-cap state) up to the full verdict-plus-punitive range if the evidence of corporate knowledge and concealment is strong and the punitive finding survives. Every case is different. Past results depend on the facts of each case and do not guarantee future outcomes.
J&J’s Litigation Playbook — How the Company Fights
Johnson & Johnson is one of the most experienced defendants in American mass tort litigation. The company and its insurers have developed a sophisticated playbook for defending talc cases. If you are considering a claim, here is what you are up against — and how each play is countered.
Play 1: The bankruptcy strategy. J&J created LTL Management LLC and Red River Talc LLC to wall off talc liability and file for bankruptcy — a maneuver designed to freeze all litigation and force claimants into a global settlement through the bankruptcy court. Three times the courts rejected this approach. The counter: the bankruptcy dismissals mean the cases are back in the tort system, and each rejection strengthens the argument that the company cannot avoid individual accountability through procedural engineering.
Play 2: The causation defense. J&J argues that mesothelioma in any given plaintiff could have come from background asbestos exposure — insulation in old buildings, automotive brake work, environmental sources — rather than from cosmetic talc. The counter: mesothelioma is a dose-responsive disease, and the exposure history must be reconstructed carefully. Product identification evidence (proof of regular, long-term baby powder use) combined with the exclusion of other significant asbestos sources builds the causal link. Expert testimony from mineralogists, epidemiologists, and occupational medicine specialists connects the talc exposure to the disease.
Play 3: The regulatory compliance argument. J&J argues it complied with all applicable FDA regulations — and since the FDA does not require asbestos testing in cosmetic talc, the company did nothing wrong. The counter: compliance with a regulatory minimum is not a defense to strict products liability. California law, like the law of most states, treats federal regulatory compliance as a floor, not a ceiling. A product can be legally sold and still be defectively designed. The FDA’s failure to require testing does not absolve a manufacturer of the duty to ensure its product is safe — especially when the company’s own testing allegedly detected asbestos.
Play 4: The preemption argument. In some product liability cases, defendants argue that federal regulatory approval of a product preempts state-law tort claims. J&J has not had a strong preemption argument in talc cases because the FDA never approved cosmetic talc as safe — it simply never required testing. Unlike prescription drugs (where FDA approval can create preemption arguments) or medical devices (where FDA premarket approval can trigger preemption), cosmetic talc was never put through a federal safety review. The regulatory gap that hurts consumers in the marketplace actually helps plaintiffs in the courtroom — because there is no federal safety finding to hide behind.
Play 5: The “not our talc” defense. J&J has argued in some cases that its talc was asbestos-free, that its testing showed no contamination, and that plaintiff experts used unreliable testing methods. The counter: the scientific literature, FDA surveys, and the company’s own internal documents — produced in discovery and now part of the litigation record — are the battleground. Transmission electron microscopy, the method capable of detecting asbestos fibers in talc at the levels relevant to cosmetic exposure, is the gold standard. The fight over testing methodology is a fight over evidence, and it is won with qualified experts and rigorous analysis.
The Proof Story — How a Talc Mesothelioma Case Is Built
Here is how a case like this is actually built, from the day you call a lawyer to the day a verdict is rendered.
Week one: the intake and preservation. The first call triggers a series of immediate actions. The complete medical record is ordered — pathology reports, imaging studies, treatment notes, physician statements. The exposure history is reconstructed in detail: every job, every home, every product used regularly over a lifetime. Family members are identified who can corroborate the product usage pattern. If the client is still alive, their testimony is preserved — because mesothelioma patients can decline rapidly, and a deposition taken in the first weeks may be the only opportunity to capture their account.
Months one through three: the expert phase. The case needs experts in multiple disciplines. A forensic pathologist or pulmonologist confirms the mesothelioma diagnosis and cell type. A mineralogist or analytical chemist tests remaining product samples (if available) for asbestos contamination using transmission electron microscopy. An epidemiologist opines on the causal link between cosmetic talc use and mesothelioma. An occupational medicine specialist reconstructs the exposure history and rules out alternative asbestos sources. A life-care planner projects the cost of treatment and care. A forensic economist calculates lost earning capacity and present-value damages.
Months three through twelve: discovery. Written discovery (interrogatories, requests for production) forces the defendant to produce internal documents — testing results, corporate communications, marketing materials, regulatory filings. Depositions of corporate witnesses extract testimony about what the company knew, when it knew it, and what it did (or did not do) in response. The discovery record in the MDL provides a foundation, but case-specific discovery is still necessary.
Year one through two: the motion practice and trial. Daubert motions challenge the admissibility of expert testimony. Summary judgment motions test whether the case survives as a matter of law. Jury instructions are negotiated. The trial itself — which in the Los Angeles case produced the $966 million verdict — is the culmination of all of this work, and it is where the evidence, the experts, and the law converge into a jury’s judgment.
For a mesothelioma patient, the timeline is cruel. The disease does not wait for the legal system. This is why many talc cases are expedited — California has procedures for preference settings that can move a case to trial quickly when the plaintiff has a terminal diagnosis with limited life expectancy.
Your First Steps — A Roadmap for the Newly Diagnosed
If you or someone you love has been diagnosed with mesothelioma and you suspect talc products may be the cause, here is what to do — and what not to do.
1. Focus on medical care first. The diagnosis is the priority. Get the best treatment available. Follow your oncologist’s recommendations. Consider seeking a second opinion at a specialized cancer center with mesothelioma expertise. Your health comes before any legal consideration.
2. Document your product usage history now. While memories are fresh — yours and your family members’ — write down everything you can remember about baby powder and talc product use. What brand. How often. For how many years. Who in the household used it. Where it was purchased. Whether you still have any containers. This information fades, and family members who can corroborate your usage pattern are critical witnesses.
3. Preserve physical evidence. If you still have talc product containers in your home, do not discard them. The physical product can be tested for asbestos contamination. Photograph the containers, the labels, and any lot numbers or manufacturing codes. Store them safely.
4. Do not give recorded statements to anyone. If an insurance adjuster, a representative of any company, or anyone purporting to be from a “claims department” contacts you, do not provide a recorded statement. Do not sign any documents. Do not accept any settlement check. Everything you say can and will be used against your case.
5. Check the statute of limitations. California’s deadline for personal injury and wrongful death claims is generally two years — but the discovery rule for latent diseases means the clock typically starts at diagnosis, not at exposure. Even so, time is critical. The earlier you consult counsel, the more evidence can be preserved and the stronger the case can be built. If your loved one has already passed away, the wrongful death clock is running from the date of death — and the estate’s survival claim clock may be running from a different date.
6. Call a lawyer who handles toxic tort and mesothelioma cases. Not every personal injury lawyer has the resources, the expert network, or the experience to handle a talc mesothelioma case. These are complex product liability cases that require specialized knowledge of asbestos science, mineralogy, epidemiology, and the specific regulatory framework governing cosmetic talc. The consultation should be free. The firm should work on contingency — you pay nothing unless you win.
Frequently Asked Questions
Can I still file a talc mesothelioma lawsuit if I was diagnosed years ago?
It depends on your state’s statute of limitations and when you discovered — or should have discovered — the connection between your mesothelioma and talc exposure. California applies a discovery rule for latent diseases, meaning the clock typically starts when you knew or reasonably should have known your injury was caused by the exposure. For most mesothelioma patients, that is the date of diagnosis or the date a doctor explained the asbestos connection. If you were diagnosed within the last two years in California, you likely still have time. But every state is different, and some impose outer deadlines that can cut off a claim even before discovery. The safest move is to call a lawyer immediately for a deadline evaluation.
What does it mean that the judge threw out $950 million in punitive damages?
It means the judge found the evidence presented at trial was not strong enough — under California’s heightened punitive damages standard — to prove that Johnson & Johnson acted with malice or consciously concealed knowledge that its talc contained asbestos. The compensatory damages (approximately $16 million) and the jury’s finding that J&J’s product caused the mesothelioma remain intact. The plaintiffs are appealing the punitive reversal, arguing the judge applied the wrong legal standard. The appeal could restore the punitive award, order a new trial on punitives, or uphold the reversal. The case is not over.
Does the verdict reversal mean J&J won?
No. Johnson & Johnson did not win. The jury found the company’s product caused the mesothelioma, and that finding stands. The $16 million compensatory award stands. What the judge reversed was the punishment portion — the $950 million in punitive damages — on the specific legal ground that the evidence did not meet California’s heightened standard for punitives. That ruling is being appealed. The liability finding, the causation finding, and the compensatory award are all intact.
How long do I have to file a wrongful death claim if my loved one died of mesothelioma?
In California, the wrongful death statute of limitations is generally two years from the date of death, under Code of Civil Procedure § 335.1. If your loved one died within the last two years, the claim may still be viable. If more than two years have passed, there may be exceptions or tolling rules that apply — but you should not wait to find out. Call a lawyer immediately. Time is the one thing that cannot be recovered in these cases.
Do I need to prove I used Johnson & Johnson baby powder specifically?
Yes. Product identification is a critical element of a talc mesothelioma case. You must establish that you used the specific product — J&J baby powder or another talc-containing product made by the defendant — with enough regularity and over enough time to constitute a meaningful exposure. This is done through your own testimony, family member corroboration, photographs of product containers, receipts, and any other evidence that documents your usage pattern. The defense will challenge product identification aggressively, so the evidence must be as detailed and well-documented as possible.
What if I was also exposed to asbestos at work or in old buildings?
You still may have a valid talc claim. Mesothelioma is a dose-responsive disease — the more asbestos fibers inhaled, the higher the risk. Multiple exposure sources do not eliminate any single source’s contribution. However, the defense will argue that your mesothelioma came from occupational or environmental asbestos rather than from cosmetic talc. Your counsel must work with experts to reconstruct your complete exposure history, quantify each source’s contribution, and establish that talc exposure was a substantial contributing factor. Alternative exposure sources make the case more complex — but they do not automatically defeat it.
How much does it cost to hire a talc mesothelioma lawyer?
Our firm works on contingency. That means you pay nothing upfront and nothing out of pocket. We advance the costs of the case — expert witnesses, document production, filing fees, discovery expenses — and those costs are repaid from the recovery if we win. Our fee is 33.33% of the recovery before trial and 40% if the case goes to trial. If we do not win, you owe us nothing. We do not get paid unless we win your case. The consultation is free, and it is confidential.
Is it too late to join the talc litigation against Johnson & Johnson?
No. While more than 68,000 cases are already pending in the federal MDL, new cases are still being filed. The MDL is a pretrial consolidation — it handles shared discovery and pretrial motions, but each plaintiff retains an individual case. If you have been diagnosed with mesothelioma and you believe talc products contributed to your disease, you can still file a claim. The deadline that matters is your state’s statute of limitations, which — with the discovery rule — typically starts at diagnosis. Call us to evaluate your specific deadline.
What if I used talc products but have not been diagnosed with mesothelioma or cancer?
If you have used talc products regularly but have not been diagnosed with mesothelioma, ovarian cancer, or another asbestos-related or talc-related disease, you do not currently have a basis for a personal injury claim. The legal system requires an actual injury — a diagnosis — to support a claim. However, if you have concerns about your exposure, you should discuss them with your physician. Some talc litigation includes medical monitoring claims in certain jurisdictions, but those claims have specific legal requirements that vary by state. If you later receive a diagnosis, contact a lawyer immediately at that point.
Why Attorney911
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes cases in California and across the country, working with local counsel where required. We handle toxic tort, product liability, and wrongful death cases — the kind of cases where a corporation put a product on the market and someone paid the price.
Ralph Manginello is our Managing Partner. He has spent 27+ years in courtrooms, including federal court. He was a journalist before he was a lawyer — which means he knows how to find the story the evidence tells, and how to tell it to a jury. He is admitted to the U.S. District Court for the Southern District of Texas, and he takes cases nationwide. He is a member of the Texas Trial Lawyers Association and the Houston Bar Association, and he is lead counsel in an active $10 million hazing lawsuit. He handles the complex litigation work that toxic tort and product liability cases demand — the motion practice, the expert development, the trial strategy.
Lupe Peña is our associate attorney. He spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims exactly like yours. He sat across the table from the defense. He knows how claim valuation works from the inside — how reserves are set, how IME doctors are selected, how surveillance is deployed, how delay tactics are engineered. Now he sits on your side of the table. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter. If your family is more comfortable in Spanish, your case will be handled in the language you actually think in.
We work on contingency. We do not get paid unless we win your case. The consultation is free. The call is confidential. And we have live staff available 24 hours a day, 7 days a week — not an answering service, but people who can start helping you the moment you reach out.
If you or someone you love has been diagnosed with mesothelioma after using talc products, the time to call is now — not because the deadline is tomorrow, but because the evidence is fading and the medical reality of this disease does not wait. The preservation letter goes out the day you call. The exposure history is documented while memories are still fresh. The medical record is ordered while the diagnostic trail is still complete.
Hablamos Español. Lupe conducts full consultations in Spanish, and our bilingual staff is ready to help your family in the language you are most comfortable speaking.
Call us at 1-888-ATTY-911 (1-888-288-9911). Free consultation. No fee unless we win. Past results depend on the facts of each case and do not guarantee future outcomes — but the fight is real, the law is on your side, and the time to start is today.
If you want to learn more about how we approach toxic tort claims, or if your family is dealing with the loss of a loved one and you need to understand your wrongful death rights, those pages walk you through the process in detail. You can also read about Ralph Manginello and Lupe Peña — their backgrounds, their experience, and why the insurance industry’s playbook is something we know from the inside. When you are ready, contact us and we will start working the same day.